pubmed-article:8874911 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8874911 | lifeskim:mentions | umls-concept:C0027679 | lld:lifeskim |
pubmed-article:8874911 | lifeskim:mentions | umls-concept:C0700323 | lld:lifeskim |
pubmed-article:8874911 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
pubmed-article:8874911 | lifeskim:mentions | umls-concept:C2698651 | lld:lifeskim |
pubmed-article:8874911 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:8874911 | pubmed:dateCreated | 1997-1-9 | lld:pubmed |
pubmed-article:8874911 | pubmed:abstractText | The aim of the study was to determine the optimum time for administration of neostigmine during recovery from atracurium-induced neuromuscular blockade. | lld:pubmed |
pubmed-article:8874911 | pubmed:language | eng | lld:pubmed |
pubmed-article:8874911 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8874911 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8874911 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8874911 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8874911 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8874911 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8874911 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8874911 | pubmed:month | Sep | lld:pubmed |
pubmed-article:8874911 | pubmed:issn | 0832-610X | lld:pubmed |
pubmed-article:8874911 | pubmed:author | pubmed-author:JensenE WEW | lld:pubmed |
pubmed-article:8874911 | pubmed:author | pubmed-author:Helbo-HansenH... | lld:pubmed |
pubmed-article:8874911 | pubmed:author | pubmed-author:PedersenH SHS | lld:pubmed |
pubmed-article:8874911 | pubmed:author | pubmed-author:LindholmPP | lld:pubmed |
pubmed-article:8874911 | pubmed:author | pubmed-author:SeverinsenI... | lld:pubmed |
pubmed-article:8874911 | pubmed:author | pubmed-author:Kirkegaard-Ni... | lld:pubmed |
pubmed-article:8874911 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8874911 | pubmed:volume | 43 | lld:pubmed |
pubmed-article:8874911 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8874911 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8874911 | pubmed:pagination | 932-8 | lld:pubmed |
pubmed-article:8874911 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:meshHeading | pubmed-meshheading:8874911-... | lld:pubmed |
pubmed-article:8874911 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8874911 | pubmed:articleTitle | Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. | lld:pubmed |
pubmed-article:8874911 | pubmed:affiliation | Department of Anaesthesia and Intensive Care, Odense University Hospital, Denmark. | lld:pubmed |
pubmed-article:8874911 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8874911 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8874911 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |